OTX008 - CAS 286936-40-1
Catalog number: 286936-40-1
Category: Inhibitor
Please be kindly noted products are not for therapeutic use. We do not sell to patients.
Molecular Formula:
C52H72N8O8
Molecular Weight:
937.18
COA:
Inquire
Targets:
Others
Description:
OTX008, a calixarene derivative, is a galectin-1 (Gal-1) inhibitor with potential anti-angiogenic and antineoplastic activities. In vitro, OTX008 effects in a panel of human cancer cell lines. In vivo, an ovarian xenograft model was employed to analyse the antitumour activity.
Purity:
>98%
Appearance:
Solid powder
Synonyms:
Acetamide, 2,2',2'',2'''-[pentacyclo[19.3.1.13,7.19,13.115,19]octacosa-1(25),3,5,7(28),9,11,13(27),15,17,19(26),21,23-dodecaene-5,11,17,23-tetrayltetrakis(oxy)]tetrakis[N-[2-(dimethylamino)ethyl]-.; OTX-008; OTX 008; OTX008; PTX008; PTX-008; PTX 008; calixarene 0118; N(2dimethylamino)ethyl)acetamidyl calix4arene
MSDS:
Inquire
InChIKey:
CQVAQQNDZCZBSU-UHFFFAOYSA-N
InChI:
1S/C52H72N8O8/c1-57(2)25-21-53-45(61)33-65-49-37-13-9-14-38(49)30-40-16-11-18-42(51(40)67-35-47(63)55-23-27-59(5)6)32-44-20-12-19-43(52(44)68-36-48(64)56-24-28-60(7)8)31-41-17-10-15-39(29-37)50(41)66-34-46(62)54-22-26-58(3)4/h9-20H,21-36H2,1-8H3,(H,53,61)
Canonical SMILES:
CN(C)CCNC(=O)COC1=C2CC3=C(C(=CC=C3)CC4=C(C(=CC=C4)CC5=CC=CC(=C5OCC(=O)NCCN(C)C)CC1=CC=C2)OCC(=O)NCCN(C)C)OCC(=O)NCCN(C)C
1.Inhibition of Galectin-1 Sensitizes HRAS-driven Tumor Growth to Rapamycin Treatment.
Michael JV;Wurtzel JG;Goldfinger LE Anticancer Res. 2016 Oct;36(10):5053-5061.
The goal of this study was to develop combinatorial application of two drugs currently either in active use as anticancer agents (rapamycin) or in clinical trials (OTX008) as a novel strategy to inhibit Harvey RAS (HRAS)-driven tumor progression. HRAS anchored to the plasma membrane shuttles from the lipid ordered (L;o;) domain to the lipid ordered/lipid disordered border upon activation, and retention of HRAS at these sites requires galectin-1. We recently showed that genetically enforced L;o; sequestration of HRAS inhibited mitogen-activated protein kinase (MAPK) signaling, but not phoshatidylinositol 3-kinase (PI3K) activation. Here we show that inhibition of galectin-1 with OTX008 sequestered HRAS in the L;o; domain, blocked HRAS-mediated MAPK signaling, and attenuated HRAS-driven tumor progression in mice. HRAS-driven tumor growth was also attenuated by treatment with mammalian target of rapamycin (mTOR) inhibitor rapamycin, and this effect was further enhanced in tumors driven by L;o;-sequestered HRAS. These drugs also revealed bidirectional cross-talk in HRAS pathways. Moreover, dual pathway inhibition with OTX008 and rapamycin resulted in nearly complete ablation of HRAS-driven tumor growth.
2.Suppression of Retinal Neovascularization by Inhibition of Galectin-1 in a Murine Model of Oxygen-Induced Retinopathy.
Yang N;Zhang W;He T;Xing Y J Ophthalmol. 2017;2017:5053035. doi: 10.1155/2017/5053035. Epub 2017 Mar 24.
Galectin-1 (Gal-1) has been proved to be an important factor in the process of tumor angiogenesis recently. As a small molecule, OTX008 serves as a selective inhibitor of Gal-1. In this study, the role of Gal-1 and the antiangiogenic effect of OTX008 on retinal neovascularization (RNV) were investigated using a mouse model of oxygen-induced retinopathy. The outcome indicated that Gal-1 was overexpressed and closely related to retinal neovessels in OIR. After intravitreal injection of OTX008 at P12, the RNV was significantly reduced at P17, measuring by cross-sectional H&E staining and whole-mount fluorescence. Our results demonstrate the inhibitory function of OTX008 on RNV, which provides a promising strategy of treating retinal angiogenic diseases such as retinopathy of prematurity and proliferative diabetic retinopathy.
3.Galectin-1 is a new fibrosis protein in type 1 and type 2 diabetes.
Al-Obaidi N;Mohan S;Liang S;Zhao Z;Nayak BK;Li B;Sriramarao P;Habib SL FASEB J. 2018 Jul 5:fj201800555RR. doi: 10.1096/fj.201800555RR. [Epub ahead of print]
Chronic exposure of tubular renal cells to high glucose contributes to tubulointerstitial changes in diabetic nephropathy. In the present study, we identified a new fibrosis gene called galectin-1 (Gal-1), which is highly expressed in tubular cells of kidneys of type 1 and type 2 diabetic mouse models. Gal-1 protein and mRNA expression showed significant increase in kidney cortex of heterozygous Akita;+/-; and db/db mice compared with wild-type mice. Mouse proximal tubular cells exposed to high glucose showed significant increase in phosphorylation of Akt and Gal-1. We cloned Gal-1 promoter and identified the transcription factor AP4 as binding to the Gal-1 promoter to up-regulate its function. Transfection of cells with plasmid carrying mutations in the binding sites of AP4 to Gal-1 promoter resulted in decreased protein function of Gal-1. In addition, inhibition of Gal-1 by OTX-008 showed significant decrease in p-Akt/AP4 and protein-promoter activity of Gal-1 and fibronectin. Moreover, down-regulation of AP4 by small interfering RNA resulted in a significant decrease in protein expression and promoter activity of Gal-1. We found that kidney of Gal-1;-/-; mice express very low levels of fibronectin protein.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Products


CAS 1354359-53-7 JW 480

JW 480
(CAS: 1354359-53-7)

JW 480 has been found to be a potent and selective inhibitor of KIAA1363 (AADACL1), which is a kind of serine hydrolase enzyme.

CAS 57644-54-9 Gastrodenol

Gastrodenol
(CAS: 57644-54-9)

Gastrodenol is a mineral that is used in treating ulcers and upset stomach.

CAS 834-28-6 Phenformin HCl

Phenformin HCl
(CAS: 834-28-6)

Phenformin HCl is a hydrochloride salt of phenformin that is an anti-diabetic drug from the biguanide class.

CAS 93265-81-7 Ropidoxuridine

Ropidoxuridine
(CAS: 93265-81-7)

Ropidoxuridine is a novel, orally available 5-substituted 2-pyrimidinone-2'-deoxyribonucleoside analogue and prodrug of 5-iododeoxyuridine (IUdR). It has radios...

AEB-1102

AEB-1102 is a derivative of human arginase that is more effective and stable for argine levels modulation compared to native human arginase I. It is potentially...

CAS 52757-95-6 Sevelamer

Sevelamer
(CAS: 52757-95-6)

Sevelamer is a phosphate binding drug used to treat hyperphosphatemia in patients with chronic kidney disease. It consists of polyallylamine that is crosslinked...

CAS 475203-77-1 Mebeverine Acid

Mebeverine Acid
(CAS: 475203-77-1)

Mebeverine Acid is a metabolite of Mebeverine, an antispasmodic. Mebeverine acid appears to be a valuable marker of oral exposure to Mebeverine.

CAS 304-20-1 Hydralazine hydrochloride

Hydralazine hydrochloride
(CAS: 304-20-1)

Hydralazine HCl is a hydrochloride salt of hydralazine (Apresoline) that is a direct-acting smooth muscle relaxant with an IC50 of 1.9 mM.

Quick Inquiry

Verification code

Featured Items